Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
CCAAT/enhancer binding protein ε is a potential retinoid target gene in acute promyelocytic leukemia treatment
Dorothy J. Park, … , Wilson H. Miller Jr., H. Phillip Koeffler
Dorothy J. Park, … , Wilson H. Miller Jr., H. Phillip Koeffler
Published May 15, 1999
Citation Information: J Clin Invest. 1999;103(10):1399-1408. https://doi.org/10.1172/JCI2887.
View: Text | PDF
Article Article has an altmetric score of 3

CCAAT/enhancer binding protein ε is a potential retinoid target gene in acute promyelocytic leukemia treatment

  • Text
  • PDF
Abstract

The CCAAT/enhancer binding protein ε (C/EBPε) is a nuclear transcription factor expressed predominantly in myeloid cells and implicated as a potential regulator of myeloid differentiation. We show that it was rapidly induced in the acute promyelocytic leukemia (APL) cell line NB4 during granulocytic differentiation after exposure to retinoic acid (RA). Our data suggest that induction of C/EBPε expression was through the retinoic acid receptor α (RARα) pathway. Reporter gene studies showed that C/EBPε promoter/enhancer activity increased in a retinoid-dependent fashion via the retinoic acid response element (RARE) present in the promoter region of C/EBPε. The RA-induced expression of C/EBPε markedly increased in U937 myelomonoblasts that were induced to express promyelocytic leukemia/RARα (PML/RARα), but not in those induced to express promyelocytic leukemia zinc finger/RARα (PLZF/RARα). In retinoid-resistant APL cell lines, C/EBPε either is not induced or is induced only at very high concentrations of RA (≥10–6 M). In addition, forced expression of C/EBPε in the U937 myelomonoblastic leukemia cells mimicked terminal granulocytic differentiation, including morphologic changes, increased CD11b/CD66b expression, and induction of secondary granule protein expression. Our data strongly suggest that C/EBPε is a downstream target gene responsible for RA-induced granulocytic differentiation of APL cells.

Authors

Dorothy J. Park, Alexey M. Chumakov, Peter T. Vuong, Doris Y. Chih, Adrian F. Gombart, Wilson H. Miller Jr., H. Phillip Koeffler

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
Induction of C/EBPε expression by retinoid receptor–selective ligands in...
Induction of C/EBPε expression by retinoid receptor–selective ligands in NB4 cells. NB4 cells were incubated with retinoid receptor–selective ligands (5 × 10–7 M) and harvested for total RNA or total cell lysates. (a) Western blot analysis of C/EBPε. NB4 cells were harvested after 2 and 4 days of induction of differentiation. COS-1 cells transfected with either C/EBPε expression vector or empty vector were used as positive (+) and negative (–) controls. Arrows denote C/EBPε. (b) Northern blot analysis for C/EBPε mRNA by hybridization with full-length C/EBPε cDNA probe. The top panel shows the C/EBPε mRNA of 1.2 kb, and the bottom panel shows the ethidium bromide–stained 28S and 18S bands to confirm equivalent loading of RNA.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 patents
42 readers on Mendeley
See more details